Report

Global Transdermal Drug Delivery System Market Size study, by Type (Transdermal Patches, Transdermal Semisolids), by Applications (Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases, Other Applications), by End use( Home Care Settings, Hospitals & Clinics)and Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Transdermal Drug Delivery System Market , by Region, 2019-2027 (USD Billion)
1.2.2. Transdermal Drug Delivery System Market , by Type, 2019-2027 (USD Billion)
1.2.3. Transdermal Drug Delivery System Market , by Applications, 2019-2027 (USD Billion)
1.2.4. Transdermal Drug Delivery System Market , by End use, 2019-2027 (USD Billion)
1.2.5.
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Transdermal Drug Delivery System Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Transdermal Drug Delivery System Market Dynamics
3.1. Transdermal Drug Delivery System Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing Prevalence of Chronic Diseases
3.1.1.2. Technological Advancements in Transdermal Drug Delivery Systems
3.1.2. Market Restraint
3.1.2.1. Drug Failure and Recalls of Transdermal Drug Delivery Systems
3.1.3. Market Opportunities
3.1.3.1. Collaborations Between Pharmaceutical Companies and Drug Delivery Firms
Chapter 4. Global Transdermal Drug Delivery System Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Transdermal Drug Delivery System Market , by Type
5.1. Market Snapshot
5.2. Global Transdermal Drug Delivery System Market by Type , Performance - Potential Analysis
5.3. Global Transdermal Drug Delivery System Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Transdermal Drug Delivery System Market , Sub Segment Analysis
5.4.1. Transdermal Patches
5.4.2. Transdermal Semisolids
Chapter 6. Global Transdermal Drug Delivery System Market , by Applications
6.1. Market Snapshot
6.2. Global Transdermal Drug Delivery System Market by Applications, Performance - Potential Analysis
6.3. Global Transdermal Drug Delivery System Market Estimates & Forecasts by Applications 2018-2027 (USD Billion)
6.4. Transdermal Drug Delivery System Market , Sub Segment Analysis
6.4.1. Pain Management
6.4.2. Hormonal Applications
6.4.3. Central Nervous System Disorders
6.4.4. Cardiovascular Diseases
6.4.5. Other Applications
Chapter 7. Global Transdermal Drug Delivery System Market , by End use
7.1. Market Snapshot
7.2. Global Transdermal Drug Delivery System Market by End use, Performance - Potential Analysis
7.3. Global Transdermal Drug Delivery System Market Estimates & Forecasts by End use 2018-2027 (USD Billion)
7.4. Transdermal Drug Delivery System Market , Sub Segment Analysis
7.4.1. Home Care Settings
7.4.2. Hospitals & Clinics
Chapter 8. Global Transdermal Drug Delivery System Market , Regional Analysis
8.1. Transdermal Drug Delivery System Market , Regional Market Snapshot
8.2. North America Transdermal Drug Delivery System Market
8.2.1. U.S. Transdermal Drug Delivery System Market
8.2.1.1. Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Applications breakdown estimates & forecasts, 2018-2027
8.2.1.3. End use breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Transdermal Drug Delivery System Market
8.3. Europe Transdermal Drug Delivery System Market Snapshot
8.3.1. U.K. Transdermal Drug Delivery System Market
8.3.2. Germany Transdermal Drug Delivery System Market
8.3.3. France Transdermal Drug Delivery System Market
8.3.4. Spain Transdermal Drug Delivery System Market
8.3.5. Italy Transdermal Drug Delivery System Market
8.3.6. Rest of Europe Transdermal Drug Delivery System Market
8.4. Asia-Pacific Transdermal Drug Delivery System Market Snapshot
8.4.1. China Transdermal Drug Delivery System Market
8.4.2. India Transdermal Drug Delivery System Market
8.4.3. Japan Transdermal Drug Delivery System Market
8.4.4. Australia Transdermal Drug Delivery System Market
8.4.5. South Korea Transdermal Drug Delivery System Market
8.4.6. Rest of Asia Pacific Transdermal Drug Delivery System Market
8.5. Latin America Transdermal Drug Delivery System Market Snapshot
8.5.1. Brazil Transdermal Drug Delivery System Market
8.5.2. Mexico Transdermal Drug Delivery System Market
8.6. Rest of The World Transdermal Drug Delivery System Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Hisamitsu Pharmaceutical
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Mylan N.V.
9.2.3. Echo Therapeutics
9.2.4. Novartis AG
9.2.5. Johnson & Johnson
9.2.6. Boehringer Ingelheim GmbH
9.2.7. Bayer AG
9.2.8. Bristol-Myers Squibb Company
9.2.9. GlaxoSmithKline plc
9.2.10. Acrux Limited

Chapter 10. Research Applications
10.1. Research Applications
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption